|
[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S.W., Zeng, H.M., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Baniak, N., Senger, J.L., Ahmed, S., Kanthan, S.C. and Kanthan, R. (2016) Gastric Biomarkers: A Global Review. World Journal of Surgical Oncology, 14, Article No. 212. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Thomassen, I., van Gestel, Y.R., van Ramshorst, B., Luyer, M.D., Bosscha, K., Nienhuijs, S.W., et al. (2014) Peritoneal Carcinomatosis of Gastric Origin: A Population-Based Study on Incidence, Survival and Risk Factors. International Journal of Cancer, 134, 622-628. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Paget, S. (1989) The Distribution of Secondary Growths in Cancer of the Breast. 1889. Cancer and Metastasis Reviews, 8, 98-101.
|
|
[6]
|
Mikuła-Pietrasik, J., Uruski, P., Tykarski, A. and Książek, K. (2018) The Peritoneal “Soil” for a Cancerous “Seed”: A Comprehensive Review of the Pathogenesis of Intraperitoneal Cancer Metastases. Cellular and Molecular Life Sciences, 75, 509-525. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kanda, M. and Kodera, Y. (2016) Molecular Mechanisms of Peritoneal Dissemination in Gastric Cancer. World Journal of Gastroenterology, 22, 6829-6840. http://dx.doi.org/10.3748/wjg.v22.i30.6829 [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Yonemura, Y., Sako, S., Wakama, S., Ishibashi, H., Mizumoto, A., Takao, N., et al. (2019) History of Peritoneal Surface Malignancy Treatment in Japan. Indian Journal of Surgical Oncology, 10, 3-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
朱小坚, 朱正明. 肿瘤微环境在胃癌腹膜转移中的作用及其分子机制研究[J]. 中国免疫学杂志, 2019, 35(15): 1916-1921. http://dx.chinadoi.cn/10.3969/j.issn.1000-484X.2019.15.025
|
|
[10]
|
Iwasa, S., Kudo, T., Takahari, D., Hara, H., Kato, K. and Satoh, T. (2020) Practical Guidance for the Evaluation of Disease Progression and the Decision to Change Treatment in Patients with Advanced Gastric Cancer Receiving Chemotherapy. International Journal of Clinical Oncology, 25, 1223-1232. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Liu, S., He, J., Liu, S., Ji, C.F., Guan, W.X., Chen, L., et al. (2020) Radiomics Analysis Using Contrast-Enhanced CT for Preoperative Prediction of Occult Peritoneal Metastasis in Advanced Gastric Cancer. European Radiology, 30, 239-246. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Borggreve, A.S., Goense, L., Brenkman, H.J.F., Mook, S., Meijer, G.J., Wessels, F.J., et al. (2019) Imaging Strategies in the Management of Gastric Cancer: Current Role and Future Potential of MRI. The British Journal of Radiology, 92, Article ID: 20181044. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Krishnamurthy, S. and Balasubramaniam, R. (2016) Role of Imaging in Peritoneal Surface Malignancies. Indian Journal of Surgical Oncology, 7, 441-452. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kim, S.J. and Lee, S.W. (2018) Diagnostic Accuracy of (18)f-fdg pet/ct for Detection of Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis. The British Journal of Radiology, 91, Article ID: 20170519. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cohen, N.A. and Kingham, T.P. (2019) Minimally Invasive Staging Surgery for Cancer. Surgical Oncology Clinics of North America, 28, 61-77.
|
|
[16]
|
Groh, E.M., Gupta, S., Brown, Z.J., Enewold, L., Gamble, L.A., Hernandez, J.M., et al. (2020) Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma. Annals of Surgical Oncology, 27, 1473-1479. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liu, K., Chen, X.Z., Zhang, W.H., Zhang, D.-Y., Luo, Y., Yu, Y., et al. (2019) “Four-Step Procedure” of Laparoscopic Exploration for Gastric Cancer in West China Hospital: A Retrospective Observational Analysis from a High-Volume Institution in China. Surgical Endoscopy, 33, 1674-1682. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Li, Z.Y., Li, Z.M., Jia, S.Q., Bu, Z.D., Zhang, L.H., Wu, X.J., et al. (2017) Depth of Tumor Invasion and Tumor-Occupied Portions of Stomach Are Predictive Factors of Intra-Abdominal Metastasis. Chinese Journal of Cancer Research, 29, 109-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Li, Z.Y., Li, Z.M., Zhang, L.H., Liu, Q., Wang, Z.J., Zhang, Z.T., et al. (2018) Staging Laparoscopy for Locally Advanced Gastric Cancer in Chinese Patients: A Multicenter Prospective Registry Study. BMC Cancer, 18, Article No. 63. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Jacquet, P. and Sugarbaker, P.H. (1996) Clinical Research Methodologies in Diagnosis and Staging of Patients with Peritoneal Carcinomatosis. In: Sugarbaker, P.H., Eds., Peritoneal Carcinomatosis: Principles of Management, Vol. 82, Springer, Boston, 359-374. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Irino, T., Sano, T., Hiki, N, Ohashi, M., Nunobe, S., Kumagai, K., et al. (2018) Diagnostic Staging Laparoscopy in Gastric Cancer: A Prospective Cohort at a Cancer Institute in Japan. Surgical Endoscopy, 32, 268-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Yonemura, Y., Canbay, E., Ishibashi, H., Hirano, M., Mizumoto, A., Takao, N., et al. (2020) Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis of Gastric Cancer. Cancer Regional Therapy. Springer, Cham, 113-124. [Google Scholar] [CrossRef]
|
|
[23]
|
Namikawa, T., Iwabu, J., Munekage, M., Uemura, S., Maeda, H., Kitagawa, H., et al. (2019) Evolution of Photodynamic Medicine Based on Fluorescence Image-Guided Diagnosis Using Indocyanine Green and 5-Aminolevulinic Acid. Surg Today, 50, 821-831. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Namikawa, T., Fujisawa, K., Munekage, E., Iwabu, J., Uemura, S., Tsujii, S., et al. (2018) Clinical Application of Photodynamic Medicine Technology Using Light-Emitting Fluorescence Imaging Based on a Specialized Luminous Source. Medical Molecular Morphology, 51, 187-193. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Koizumi, N., Harada, Y., Minamikawa, T., Tanaka, H., Otsuji, E. and Takamatsu, T. (2016) Recent Advances in Photodynamic Diagnosis of Gastric Cancer Using 5-Aminolevulinic Acid. World Journal of Gastroenterology, 22, 1289-1296. http://dx.doi.org/10.3748/wjg.v22.i3.1289 [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Hasbahceci, M., Akcakaya, A., Guler, B., Kunduz, E., Umit Malya, F. and Muslumanoglu, M. (2018) Use of Peritoneal Washing Cytology for the Detection of Free Peritoneal Cancer Cells before and after Surgical Treatment of Gastric Adenocarcinoma. Journal of Cancer Research and Therapeutics, 14, 1225-1229. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lai, H., Jin, Q.W., Lin, Y., Mo, X.W., Li, B., He, K. and Chen, J.S. (2014) Combined Use of Lysyl Oxidase, Carcino-Embryonic Antigen, and Carbohydrate Antigens Improves the Sensitivity of Biomarkers in Predicting Lymph Node Metastasis and Peritoneal Metastasis in Gastric Cancer. Tumor Biology, 35, 10547-10554. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
赵骏杰, 周荣健, 张启, 束平, 李豪杰, 汪学非, 等. 胃癌腹膜转移风险评估模型的建立及其预测价值[J]. 中华胃肠外科杂志, 2017, 20(1): 47-52. http://dx.chinadoi.cn/10.3760/cma.j.issn.1671-0274.2017.01.010
|
|
[29]
|
Ge, W., Zheng, L.M. and Chen, G. (2018) The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV. Gastroenterology Research and Practice, 2018, Article ID: 3450981. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Zhou, J.T., Ma, X., Bi, F. and Liu, M. (2017) Clinical Significance of Circulating Tumor Cells in Gastric Cancer Patients. Oncotarget, 8, 25713-25720. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Tokuhisa, M., Ichikawa, Y., Kosaka, N., Ochiya, T., Yashiro, M., Hirakawa, K., et al. (2015) Exosomal Mirnas from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer. PLoS ONE, 10, e0130472. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Seshadri, R.A. and Glehen, O. (2016) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. World Journal of Gastroenterology, 22, 1114-1130. http://dx.doi.org/10.3748/wjg.v22.i3.1114 [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Masuda, T., Kuramoto, M., Shimada, S., Ikeshima, S., Yamamoto, K., Nakamura, K., et al. (2016) The Effect of Extensive Intraoperative Peritoneal Lavage Therapy (EIPL) on Stage III B + C and Cytology-Positive Gastric Cancer Patients. International Journal of Clinical Oncology, 21, 289-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Beeharry, M.K., Ni, Z.T., Yang, Z.Y., Zheng, Y.N., Feng, R.H., Liu, W.-T., et al. (2020) Study Protocol of a Multicenter Phase III Randomized Controlled Trial Investigating the Efficiency of the Combination of Neoadjuvant Chemotherapy (NAC) and Neoadjuvant Laparoscopic Intraperitoneal Hyperthermic Chemotherapy (NLHIPEC) Followed by R0 Gastrectomy with Intraoperative HIPEC for Advanced Gastric Cancer (AGC): Dragon II Trial. BMC Cancer, 20, Article No. 224. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Wang, F.H., Shen, L., Li, J., Zhou, Z.-W., Liang, H., Zhang, X.-T., et al. (2019) The Chinese Society of Clinical Oncology (CSCO): Clinical Guidelines for the Diagnosis and Treatment of Gastric Cancer. Cancer Communications, 39, 1-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Ajani, J.A., D’Amico, A., Almhanna, K., Bentrem, D.J., Chao, J., Das, P., et al. (2016) Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 14, 1286-1312. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Japanese Gastric Cancer Association (2017) Japanese Gastric Cancer Treatment Guidelines 2014 (ver. 4). Gastric Cancer, 20, 1-19. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, Z., Chen, J.Q., Liu, J.L. and Tian, L. (2019) Issues on Peritoneal Metastasis of Gastric Cancer: An Update. World Journal of Surgical Oncology, 17, Article No. 215. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Ji, Z.H., Peng, K.W., Yu, Y., Li, X.-B., Yonemura, Y., Liu, Y., et al. (2017) Current Status and Future Prospects of Clinical Trials on CRS + HIPEC for Gastric Cancer Peritoneal Metastases. International Journal of Hyperthermia, 33, 562-570. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Ishigami, H., Fujiwara, Y., Fukushima, R., Nashimoto, A., Yabusaki, H., Imano, M., et al. (2018) Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer with Peritoneal Metastasis: PHOENIX-GC Trial. Journal of Clinical Oncology, 36, 1922-1929. [Google Scholar] [CrossRef]
|
|
[41]
|
Li, H.K., Morokoshi, Y., Nagatsu, K., Kamada, T. and Hasegawa, S, (2017) Locoregional Therapy with α-Emitting Trastuzumab against Peritoneal Metastasis of Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer in Mice. Cancer Science, 108, 1648-1656. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Kagawa, S., Shigeyasu, K., Ishida, M., Watanabe, M., Tazawa, H., Nagasaka, T., et al. (2014) Molecular Diagnosis and Therapy for Occult Peritoneal Metastasis in Gastric Cancer Patients. World Journal of Gastroenterology, 20, 17796-17803. http://dx.doi.org/10.3748/wjg.v20.i47.17796 [Google Scholar] [CrossRef] [PubMed]
|